NDC 69097-868

Nadolol

Nadolol

Nadolol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Nadolol.

Product ID69097-868_04cca80e-cd0b-467d-9017-32fe1380e044
NDC69097-868
Product TypeHuman Prescription Drug
Proprietary NameNadolol
Generic NameNadolol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-02-23
Marketing CategoryANDA / ANDA
Application NumberANDA203455
Labeler NameCipla USA Inc.
Substance NameNADOLOL
Active Ingredient Strength40 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69097-868-02

30 TABLET in 1 BOTTLE (69097-868-02)
Marketing Start Date2016-02-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69097-868-15 [69097086815]

Nadolol TABLET
Marketing CategoryANDA
Application NumberANDA203455
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-23

NDC 69097-868-02 [69097086802]

Nadolol TABLET
Marketing CategoryANDA
Application NumberANDA203455
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-02-23

NDC 69097-868-07 [69097086807]

Nadolol TABLET
Marketing CategoryANDA
Application NumberANDA203455
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-02-23

Drug Details

Active Ingredients

IngredientStrength
NADOLOL40 mg/1

OpenFDA Data

SPL SET ID:c899eedb-4113-45da-acc3-8e181250a7d8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198006
  • 198007
  • 198008
  • UPC Code
  • 0369097867072
  • 0369097868079
  • 0369097869076
  • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    Medicade Reported Pricing

    69097086807 NADOLOL 40 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Nadolol" or generic name "Nadolol"

    NDCBrand NameGeneric Name
    0093-4235NadololNadolol
    0093-4236NadololNadolol
    0093-4237NadololNadolol
    0378-0028Nadololnadolol
    0378-1132Nadololnadolol
    0378-1171Nadololnadolol
    0781-1181NadololNadolol
    0781-1182NadololNadolol
    0781-1183NadololNadolol
    0781-8004NadololNadolol
    0781-8005NadololNadolol
    0781-8006NadololNadolol
    0904-7070NadololNadolol
    0904-7071NadololNadolol
    10135-686NadololNadolol
    10135-687NadololNadolol
    10135-688NadololNadolol
    21695-799NadololNadolol
    21695-800NadololNadolol
    21695-802NadololNadolol
    23155-730NadololNadolol
    23155-731NadololNadolol
    23155-732NadololNadolol
    67787-349NadololNadolol
    67787-347NadololNadolol
    67787-348NadololNadolol
    68001-317NadololNadolol
    68001-319NadololNadolol
    68001-318NadololNadolol
    68258-6034NadololNadolol
    68382-734NadololNadolol
    68382-732NadololNadolol
    68382-733NadololNadolol
    69097-869NadololNadolol
    69238-1123NadololNadolol
    69097-867NadololNadolol
    69097-868NadololNadolol
    69238-1124NadololNadolol
    69238-1125NadololNadolol
    70518-1755NadololNadolol
    70771-1090NadololNadolol
    70771-1091NadololNadolol
    70771-1089NadololNadolol
    71335-0697NadololNadolol
    31722-349NadololNadolol
    31722-347NadololNadolol
    31722-348NadololNadolol
    42254-218NadololNadolol
    42254-094NadololNadolol
    50742-180NADOLOLNADOLOL

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.